248 CHAPTER 3.2 19. O’Mahony D, Gudmundsson A, Soiza RL, et al. Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial. Age Ageing. 2020;49:605-14. 20. Dalton K, O’Brien G, O’Mahony D, Byrne S. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis. Age Ageing. 2018;47:670–8. 21. Terrell KM, Perkins AJ, Dexter PR, Hui SL, Callahan CM, Miller DK. Computerized Decision Support to Reduce Potentially Inappropriate Prescribing to Older Emergency Department Patients: A Randomized, Controlled Trial: DECISION SUPPORT FOR INAPPROPRIATE PRESCRIBING. J Am Geriatr Soc. 2009;57:1388–94. 22. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8. 23. Drenth-van Maanen AC, Leendertse AJ, Jansen PAF, et al. The Systematic Tool to Reduce Inappropriate Prescribing (STRIP): Combining implicit and explicit prescribing tools to improve appropriate prescribing. J Eval Clin Pr. 2018;24:317–22. 24. Chiu P, Lee A, See T, Chan F. Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients. Hong Kong Med J Xianggang Yi Xue Za Zhi. 2018;24:98–106. 25. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2003;60:1123–9. 26. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2:257–64. 27. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845–54. 28. Adam L, Moutzouri E, Baumgartner C, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9:e026769. 29. Jadad AR, To MJ, Emara M, Jones J. Consideration of multiple chronic diseases in randomized controlled trials. JAMA. 2011;306:2670–2. 30. Torgerson DJ. Contamination in trials: is cluster randomisation the answer? BMJ. 2001;322:355–7. 31. Crowley EK, Sallevelt BTGM, Huibers CJA, et al. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication reviewwith support of a computerised decision support system. BMC Health Serv Res. 2020;20:220. 32. Shen Z, Meulendijk M, Spruit MR. A Federated Information Architecture for Multinational Clinical Trials: Stripa Revisited. In: 24th European Conference on Information Systems, ECIS 2016, Istanbul, Turkey, June 12-15, 2016 [Internet]. 2016. Available from: http:// aisel.aisnet.org/ecis2016_prototypes/2 33. Meulendijk MC, Spruit MR, Drenth-van Maanen AC, et al. Computerized Decision Support Improves Medication Review Effectiveness: An Experiment Evaluating the STRIP Assistant’s Usability. Drugs Aging. 2015;32:495–503.
RkJQdWJsaXNoZXIy MTk4NDMw